About
The daily drama of money and work from the BBC.
Creator
BBC World Service
host
Reviews
Episodes(5)
The worldwide weight-loss revolution
GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily series on the global w
Weight-loss drugs. Who pays?
GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market. Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — are now widely prescr
How a spiked drink led to a startup
Today - from a teenage DIY invention, to US national TV, to changing legislation, and now global sales. What started as a way to protect a friend who’d been drugged at a college bar became a product made from an old hair scrunchie and her mum’s stockings. Shirah Benarde tells us how she set up Night
How modular homes are rebuilding Portugal’s ruins
Today, we’re looking at a wooden house revolution that's happening in Europe. Concrete’s carbon footprint is turning architects and construction companies towards trees. In Portugal, a rush of new residents to the sparsely populated rural areas – and a lack of builders – is driving the flat-pack and
Are passengers ready for digital borders?
The use of electronic travel authorisations or ETAs is growing worldwide. Dozens of countries have brought them in, or are bringing them in this year, but many passengers are forgetting to complete them - and missing flights. It is costing customers and business big money to re-book. We hear the arg